Sarcopenia in Egypt: epidemiology of sarcopenia risk among older adults presenting with fragility fractures—an initiative by the Egyptian Academy of Bone Health

Egyptian Rheumatology and Rehabilitation
Yasser El Miedany1, Maha El Gaafary2, Naglaa Gadallah3, Walaa Elwakil4, Waleed Hassan5, Nihal Fathi6, Mohammed Hassan Abu-Zaid7, S. A. A. Tabra7, Radwa H. Shalaby7, Safaa Mahran6
1Canterbury Christ Church University, England, UK
2Community and Public Health, Ain Shams University, Cairo, Egypt
3Rheumatology and Rehabilitation, Ain Shams University, Cairo, Egypt
4Physical Medicine, Rheumatology and Rehabilitation, Alexandria University, Alexandria, Egypt
5Rheumatology and Rehabilitation, Benha University, Benha, Egypt
6Physical Medicine, Rheumatology and Rehabilitation, Assiut University, Assiut, Egypt
7Rheumatology and Rehabilitation, Tanta University, Tanta, Egypt

Tóm tắt

Abstract Purpose (1) This was a multi-center, cross-sectional, observational study. Both old men and postmenopausal women over 50 years old who were admitted with an osteoporotic fracture (whether hip fracture or major osteoporosis) were consecutively recruited for this work and managed under the Fracture Liaison Service. All the patients were assessed for their sarcopenia risk (SARC-F), fracture risk (FRAX), and fall risk (FRAS) as well as functional disability (HAQ). The aim was to assess the prevalence of sarcopenia risk among older adult Egyptians presenting with fragility fractures. (2) To identify the relation between sarcopenia risk with the risk of falling as well as sustaining a fragility fracture. Results Two hundred and thirty-six patients (69 males, 167 females) were included in this work. The mean age was 70.1 (SD = 9.2) years. The prevalence of sarcopenia was 69.7%. The sarcopenia risk score was positively correlated with the FRAX score (p = 0.01). The prevalence of high sarcopenia risk was 78% of the patients presenting with a high 10-year probability of major osteoporosis fracture as well as a 10-year probability of hip fracture. The sarcopenia risk score was positively correlated with the increased fall risk (p = 0.01) as scored by the FRAS scale. There was a significant relation (p < 0.05) between the functional disability score and the SARC-F score. This was persistent when assessed in relation to fall risk. Conclusion This study highlighted the high sarcopenia risk in the patients presenting with fragility fractures. Identification of patients at increased risk of sarcopenia should be a component of the standard practice.

Từ khóa


Tài liệu tham khảo

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31.

Yeung SSY, Reijnierse EM, Pham VK, Trappenburg MC, Lim WK, Meskers CGM, Maier AB (2019) Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 10(3):485–500. https://doi.org/10.1002/jcsm.12411

Yang M, Liu Y, Zuo Y, Tang H (2019) Sarcopenia for predicting falls and hospitalization in community-dwelling older adults: EWGSOP versus EWGSOP2. Sci Rep 9:17636. https://doi.org/10.1038/s41598-019-53522-6

Angulo JC, Assar ME, Rodriguezmanas L (2016) Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults. Mol Aspects Med 50:1–32

Brown JC, Harhay MO, Harhay MN (2016) Sarcopenia and mortality among a population-based sample of community dwelling older adults. J Cachexia Sarcopenia Muscle 7:290–298

Landi F, Cruz-Jentoft AJ, Liperoti R et al (2013) Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 42:203–209

Zanchetta MB, Abdala R, Massari F, Rey P, Spivacow R, Miechi L, Longobardi V, Brun LR (2021) Postmenopausal women with sarcopenia have higher prevalence of falls and vertebral fractures. Medicina (B Aires) 81(1):47–53

Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R (2017) Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies. J Diabetes Metab Disord 16:21

Reijnierse EM, Trappenburg MC, Leter MJ, Blauw GJ, Sipila S, Sillanpaa E et al (2015) The impact of different diagnostic criteria on the prevalence of sarcopenia in healthy elderly participants and geriatric outpatients. Gerontology 61:491–496

Bijlsma AY, Meskers CGM, Ling CHY, Narici M, Kurrle SE, Cameron ID et al (2013) Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Dordr) 35:871–881

Beaudart C, Dawson A, Shaw SC, Harvey NC, Kanis JA, Binkley N et al (2017) Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int 28:1817–1833 ([PMC free article] [PubMed] [Google Scholar])

Papa EV, Dong X, Hassan M (2017) Resistance training for activity limitations in older adults with skeletal muscle function deficits: a systematic review. Clin Interv Aging 12:955–961

Yuan S, Larsson SC (2023) Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism 144:155533

Abouzid MR, Ali K, Elkhawas I, Elshafei SM (2022) An overview of diabetes mellitus in Egypt and the significance of integrating preventive cardiology in diabetes management. Cureus 14(7):e27066. https://doi.org/10.7759/cureus.27066

Egypt - Country profile. https://arabstates.unfpa.org/sites/default/files/pub-pdf/country_profile_-_egypt_27-10-2021_0.pdf. Accessed 22 Oct 2023

Decline in Egyptian Smokers. https://tobaccoreporter.com/2023/06/02/decline-in-egyptian-smokers/#:~:text=The%20percentage%20of%20smokers%20in,CAPMAS)%2C%20reports%20Egyptian%20Streets. [Accessed 22 Oct 2023]

Jin H, Yoo HJ, Kim YA, Lee JH, Lee Y, Kwon SH, Seo YJ, Lee SH, Koh JM, Ji Y, Do AR, Won S, Seo JH (2022) Unveiling genetic variants for age-related sarcopenia by conducting a genome-wide association study on Korean cohorts. Sci Rep 12(1):3501. https://doi.org/10.1038/s41598-022-07567-9

El Miedany Y, Mahran S, Elwakil W (2023) One musculoskeletal health: towards optimizing musculoskeletal health in Egypt—how to be a bone and muscle builder by the Egyptian Academy of bone health and metabolic bone diseases. Egypt Rheumatol Rehabil 50:33. https://doi.org/10.1186/s43166-023-00199-5

Gabal HMS, Wahdan MM, Eldin WS (2020) Perceived benefits and barriers towards exercise among healthcare providers in Ain Shams University Hospitals, Egypt. J Egypt Public Health Assoc 95(1):19. https://doi.org/10.1186/s42506-020-00042-1

Abdelmonem M et al (2021) Vitamin D deficiency crisis in Egypt. Am J Clin Pathol 156(Supplement_1):S36. https://doi.org/10.1093/ajcp/aqab191.071

Sherief LM, Ali A, Gaballa A, Abdellatif GM, Kamal NM, Afify MR, Abdelmalek DH, El-Emari SA, Soliman ASA, Mokhtar WA (2021) Vitamin D status and healthy Egyptian adolescents: where do we stand? Medicine (Baltimore) 100(29):e26661. https://doi.org/10.1097/MD.0000000000026661

El Miedany Y, Gadallah NA, Toth M (2022) Optimizing osteoporosis management: targeting to treat — an initiative by the Egyptian Academy of bone health. Egypt Rheumatol Rehabil 49:61. https://doi.org/10.1186/s43166-022-00161-x

Sharifirad G, Charkazi A, Tashi M, Shahnazi H, Bahador E (2011) Physical activity and stages of change among college students. Health Promot Perspect 1(1):71–75

Shafiee G, Keshtkar A, Soltani A et al (2017) Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies. J Diabetes Metab Disord 16:21. https://doi.org/10.1186/s40200-017-0302-x

Burger HG, Dudley EC, Robertson DM, Dennerstein L (2002) Hormonal changes in the menopause transition. Recent Prog Horm Res 57:257–275

Juul A, Skakkebaek NE (2002) Androgens and the ageing male. Hum Reprod Update 8(5):423–433

Crepaldi G, Maggi S (2005) Sarcopenia and osteoporosis: a hazardous duet. J Endocrinol Invest 28(10 suppl):66–68

Tarantino U, Baldi J, Scimeca M, Piccirilli E, Piccioli A, Bonanno E et al (2016) The role of sarcopenia with and without fracture. Injury 47(Suppl. 4):S3–S10. https://doi.org/10.1016/j.injury.2016.07.057

Steihaug OM, Gjesdal CG, Bogen B, Kristoffersen MH, Lien G, Ranhoff AH (2017) Sarcopenia in patients with hip fracture: a multicenter cross-sectional study. PLoS One 12:e0184780. https://doi.org/10.1371/journal.pone.0184780

Marques A, Queirós C (2018) Frailty, sarcopenia and falls. In: Hertz K, Santy-Tomlinson J (eds) Fragility fracture nursing: holistic care and management of the orthogeriatric patient. Springer, Cham, pp 15–26

Cederholm T, Cruz-Jentoft AJ, Maggi S (2013) Sarcopenia and fragility fractures. Eur J Phys Rehabil Med 49(1):111–117

Girgis CM (2015) Integrated therapies for osteoporosis and sarcopenia: from signaling pathways to clinical trials. Calcif Tissue Int 96:243–255. https://doi.org/10.1007/s00223-015-9956-x

Bonewald LF, Kiel DP, Clemens TL, Esser K, Orwoll ES, O’Keefe RJ et al (2013) Forum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR workshop. J Bone Miner Res 28:1857–1865. https://doi.org/10.1002/jbmr.1980

Wong RMY, Wong H, Zhang N, Chow SKH, Chau WW, Wang J, Chim YN, Leung KS, Cheung WH (2019) The relationship between sarcopenia and fragility fracture-a systematic review. Osteoporos Int 30(3):541–553. https://doi.org/10.1007/s00198-018-04828-0

Dufresne SS, Dumont NA, Bouchard P, Lavergne É, Penninger JM, Frenette (2015) Osteoprotegerin protects against muscular dystrophy. J Am J Pathol 185(4):920–926

Miedany YE, Gaafary ME, Toth M, Hegazi MO, Aroussy NE, Hassan W, Almedany S, Nasr A, Bahlas S, Galal S, Egyptian Academy of Bone Health, Metabolic Bone Diseases (2021) Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia? Clin Rheumatol 40(10):4225–4232. https://doi.org/10.1007/s10067-021-05757-w

Thông tin
Thông tin xuất bản

Egyptian Rheumatology and Rehabilitation

Thông tin tác giả